Energy expenditure, insulin, and VLDL-triglyceride production in humans

J Lipid Res. 2006 Oct;47(10):2325-32. doi: 10.1194/jlr.M600175-JLR200. Epub 2006 Jul 18.

Abstract

Hypertriglyceridemia is considered a cardiovascular risk factor in diabetic and nondiabetic subjects. In this study, we aimed to determine potential regulators of very low density lipoprotein-triglyceride (TG) production. VLDL-TG kinetics were measured in 13 men and 12 women [body mass index [mean (range)]: 24.8 (20.2-35.6) kg/m(2)]. VLDL-TG production was assessed from the plasma decay of a bolus injection of ex vivo labeled VLDL particles ([1-(14)C]triolein-VLDL-TG). Similar VLDL-TG production (micromol/min) was found in men and women. VLDL-TG production was not significantly correlated with palmitate flux ([9,10-(3)H]palmitate) (r = 0.09, P = 0.67) or palmitate concentration (r = -0.29, P = 0.2) but was correlated significantly with fasting insulin concentration (r = 0.46, P < 0.05) and resting energy expenditure (REE) (r = 0.45, P < 0.05). The latter correlation improved when adjusted for sex. The best multivariate model with VLDL-TG production as the dependent variable and REE, body composition, hormones, and substrate levels as independent variables included fasting insulin (P = 0.02) and REE (P = 0.02) (r(2) = 0.32, P < 0.001). We conclude that VLDL kinetics are similar in men and women and that REE and plasma insulin are significant independent predictors of VLDL-TG production. FFA availability and body fat distribution are unrelated to VLDL production. We suggest that REE plays a greater role in VLDL-TG production than previously anticipated. REE and insulin should be taken into account when VLDL-TG production comparisons between groups are made.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Composition
  • Body Mass Index
  • Energy Metabolism / physiology*
  • Female
  • Human Growth Hormone / blood
  • Humans
  • Insulin / blood*
  • Kinetics
  • Lipoproteins, VLDL / biosynthesis*
  • Lipoproteins, VLDL / blood*
  • Male
  • Norepinephrine / blood
  • Triglycerides / biosynthesis*
  • Triglycerides / blood*

Substances

  • Insulin
  • Lipoproteins, VLDL
  • Triglycerides
  • very low density lipoprotein triglyceride
  • Human Growth Hormone
  • Norepinephrine